549 related articles for article (PubMed ID: 8957009)
21. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; De Haro L; Seagar M
J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
[TBL] [Abstract][Full Text] [Related]
22. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
Wirtz PW; Lang B; Graus F; van den Maagdenberg AM; Saiz A; de Koning Gans PA; Twijnstra A; Verschuuren JJ
J Neuroimmunol; 2005 Jul; 164(1-2):161-5. PubMed ID: 15904978
[TBL] [Abstract][Full Text] [Related]
23. [Lambert-Eaton syndrome without calcium channel autoantibodies].
Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
[TBL] [Abstract][Full Text] [Related]
24. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy.
Takamori M
Biochem Biophys Res Commun; 2004 Oct; 322(4):1347-51. PubMed ID: 15336982
[TBL] [Abstract][Full Text] [Related]
25. Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome.
Nakao YK; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Mori M; Itoh M; Nagataki S
J Neurol; 1999 Jan; 246(1):38-44. PubMed ID: 9987712
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to L-type calcium channels in amyotrophic lateral sclerosis.
Engel WK
N Engl J Med; 1993 May; 328(18):1356; author reply 1356-7. PubMed ID: 8385744
[No Abstract] [Full Text] [Related]
27. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.
Verschuuren JJ; Dalmau J; Tunkel R; Lang B; Graus F; Schramm L; Posner JB; Newsom-Davis J; Rosenfeld MR
Neurology; 1998 Feb; 50(2):475-9. PubMed ID: 9484375
[TBL] [Abstract][Full Text] [Related]
28. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
Eymard B
Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to L-type calcium channels in amyotrophic lateral sclerosis.
Wierzbicki AS
N Engl J Med; 1993 May; 328(18):1355-6; author reply 1356-7. PubMed ID: 8385743
[No Abstract] [Full Text] [Related]
30. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
[TBL] [Abstract][Full Text] [Related]
31. A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome.
Sauter M; Bender A; Heller F; Sitter T
Ther Apher Dial; 2010 Jun; 14(3):364-7. PubMed ID: 20609193
[TBL] [Abstract][Full Text] [Related]
32. Antibodies against the beta subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome.
Raymond C; Walker D; Bichet D; Iborra C; Martin-Moutot N; Seagar M; De Waard M
Neuroscience; 1999 Apr; 90(1):269-77. PubMed ID: 10188953
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies omega-conotoxin and adenosine.
De Aizpurua HJ; Lambert EH; Griesmann GE; Olivera BM; Lennon VA
Cancer Res; 1988 Sep; 48(17):4719-24. PubMed ID: 2457429
[TBL] [Abstract][Full Text] [Related]
34. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
[TBL] [Abstract][Full Text] [Related]
35. Lambert-Eaton myasthenic syndrome in childhood.
Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; KamiĆska A
Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
[TBL] [Abstract][Full Text] [Related]
36. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
[No Abstract] [Full Text] [Related]
37. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
[No Abstract] [Full Text] [Related]
38. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
[TBL] [Abstract][Full Text] [Related]
39. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
40. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
Fletcher CF; Lennon VA
Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]